Bartsch Fabian, Heinrich Stefan, Lang Hauke
General, Visceral and Transplant Surgery, Johannes Gutenberg-University Hospital of Mainz, Mainz, Germany.
Viszeralmedizin. 2015 Jun;31(3):189-93. doi: 10.1159/000433482. Epub 2015 Jun 11.
Perihilar cholangiocarcinoma is the most frequent cholangiocarcinoma and poses difficulties in preoperative evaluation. For its therapy, often major hepatic resections as well as resection and reconstruction of the hepatic artery or the portal vein are necessary. In the last decades, great advances were made in both the surgical procedures and the perioperative anesthetic management. In this article, we describe from our point of view which facts represent the limits for curative (R0) resection in perihilar cholangiocarcinoma.
Retrospective data of a 6-year period (2008-2014) was collected in an SPSS 22 database and further analyzed with focus on the surgical approach and the postoperative as well as histological results.
Out of 96 patients in total we were able to intend a curative resection in 73 patients (76%). In 58/73 (79.5%) resections an R0 situation could be reached (R1 n = 14; R2 n = 1). 23 patients were irresectable because of peritoneal carcinosis (n = 8), broad infiltration of major blood vessels (n = 8), bilateral advanced tumor growth to the intrahepatic bile ducts (n = 3), infiltration of the complete liver hilum (n = 2), infiltration of the gallbladder (n = 1), and liver cirrhosis (n = 1). Patients with a T4 stadium were treated with curative intention twice, and in each case an R1 resection was achieved. Most patients with irresectable tumors can be suspected to have a T4 stadium as well. In a T3 situation (n = 6) we could establish five R0 resections and one R1 resection.
The limit of surgical resection for bile duct cancer is the advanced tumor stage (T stadium). While in a T3 stadium an R0 resection is possible in most cases, we were not able to perform an R0 resection in a T4 stadium. From our point of view, early T stadium cannot usually be estimated through expanded diagnostics but only through surgical exploration.
肝门部胆管癌是最常见的胆管癌,术前评估存在困难。对于其治疗,通常需要进行大范围肝切除以及肝动脉或门静脉的切除与重建。在过去几十年中,手术操作和围手术期麻醉管理都取得了巨大进展。在本文中,我们从自身角度描述哪些因素代表了肝门部胆管癌根治性(R0)切除的限制。
在SPSS 22数据库中收集了6年期间(2008 - 2014年)的回顾性数据,并重点针对手术方式、术后及组织学结果进行进一步分析。
在总共96例患者中,我们能够对73例患者(76%)进行根治性切除。在73例切除病例中的58例(79.5%)能够达到R0状态(R1为14例;R2为1例)。23例患者因腹膜癌转移(8例)、主要血管广泛浸润(8例)、肿瘤双侧向肝内胆管进展(3例)、整个肝门浸润(2例)、胆囊浸润(1例)和肝硬化(1例)而无法切除。有2例处于T4期的患者接受了根治性治疗,且每次均实现了R1切除。大多数无法切除肿瘤的患者也可能被怀疑处于T4期。在T3期(6例),我们成功进行了5例R0切除和1例R1切除。
胆管癌手术切除的限制在于肿瘤进展期(T分期)。虽然在T3期大多数情况下可以进行R0切除,但在T4期我们无法进行R0切除。从我们的角度来看,早期T分期通常无法通过扩大诊断来评估,而只能通过手术探查来确定。